GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market - Global Forecast to 2033: With the Semaglutide Patent Expiring in 2026 Onwards, the Biosimilars Market is Expecte…

The GLP-1 agonists market is set to skyrocket, reaching USD 170.75 billion by 2033, growing from USD 64.42 billion in 2025 at ...

Liraglutide and Semaglutide Business Analysis Report 2025: Market to Reach $29.8 Billion by 2030 - Growth in Off-Label Use for Weight Loss and Metabolic Syndrome …

Key market opportunities for liraglutide and semaglutide include their growing role in diabetes and obesity treatment due to ...